CS3-04 The Echinocandins and Formulary Decision

Critical review of prasugrel for formulary decision makers.

BACKGROUND Cardiovascular disease, including acute coronary syndromes (ACS) comprising ST-elevation and non-ST-elevation myocardial infarction (STEMI/NSTEMI) and unstable angina (UA), remains the leading cause of death in the United States. The direct and indirect costs of cardiovascular disease are estimated to surpass $165 billion in 2009. Antiplatelet pharmacotherapy has been shown to reduce...

The Microtomist's Formulary and Guide

physiological variation between the early, middle, and late ripening apples was apparent. The deductions and reasoning from the experimental data by Blackman in an attempt to clarify the results make the book worthwhile even if one takes issue with his lack of a statistical basis for his conclusions. The work should, as a result, be entitled to a place in the classical researches into the compl...

A Prescription for Improving Drug Formulary Decision Making

1 Brigham and Woman’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 2 Center for Education and Research on Therapeutics, University of Illinois at Chicago, Chicago, Illinois, United States of America, 3 University of Illinois at Chicago, College of Medicine, Chicago, Illinois, United States of America, 4 Department of Pharmacy Practice, University of Illinoi...

The Formulary Decision Process: What Are They Doing in There and Can Actuaries Help?

The National Formulary